Published in Arterioscler Thromb Vasc Biol on April 16, 2008
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology (2009) 2.39
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg (2011) 1.76
Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med (2010) 1.72
25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol (2009) 1.71
The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med (2008) 1.69
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 1.62
Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials. Scand J Infect Dis (2011) 1.52
Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis (2009) 1.21
Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol (2009) 1.16
Vitamin D: a d-lightful solution for health. J Investig Med (2011) 1.15
Vitamin D status of clinical practice populations at higher latitudes: analysis and applications. Int J Environ Res Public Health (2009) 1.14
Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses (2011) 1.12
Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol (2011) 1.09
Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J (2011) 1.05
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol (2010) 1.00
Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol Aging (2009) 0.98
Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey). Am J Cardiol (2010) 0.95
Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr (2012) 0.94
Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study. Am J Epidemiol (2010) 0.93
Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinol (2009) 0.91
Predicting ambient ultraviolet from routine meteorological data; its potential use as an instrumental variable for vitamin D status in pregnancy in a longitudinal birth cohort in the UK. Int J Epidemiol (2009) 0.91
Role of vitamin d in cardiometabolic diseases. J Diabetes Res (2013) 0.88
Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev (2012) 0.88
Identification of a mechanism for increased cardiovascular risk among individuals with low vitamin D concentrations. Menopause (2011) 0.87
Vitamin D level and risk of community-acquired pneumonia and sepsis. Nutrients (2014) 0.85
The role of nutrition and body composition in peripheral arterial disease. Nat Rev Cardiol (2012) 0.84
Vitamin D and cardiovascular disease: an appraisal of the evidence. Clin Chem (2013) 0.84
Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis (2014) 0.84
Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem? Neurotherapeutics (2010) 0.83
Is vitamin d deficiency a new risk factor for cardiovascular disease? Open Cardiovasc Med J (2015) 0.82
Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged. PM R (2011) 0.82
Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study. Am J Hypertens (2011) 0.82
Low vitamin D concentration is not associated with increased mortality and morbidity after cardiac surgery. PLoS One (2013) 0.82
The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults. J Clin Endocrinol Metab (2013) 0.81
Vitamin D and cardiovascular disease. Nutrients (2010) 0.80
Nutrient supplements and cardiovascular disease: a heartbreaking story. J Lipid Res (2008) 0.80
Vitamin D and extra-skeletal health: causality or consequence. Int J Health Sci (Qassim) (2016) 0.79
Vitamin D status, functional decline, and mortality in peripheral artery disease. Vasc Med (2014) 0.79
Effect of vitamin D therapy on endothelial function in ischemic heart disease female patients with vitamin D deficiency or insufficiency: A primary report. ARYA Atheroscler (2015) 0.78
Does vitamin D have a role in reducing the risk of peripheral artery disease? Mayo Clin Proc (2010) 0.78
Vitamin D status and peripheral arterial disease: evidence so far. Vasc Health Risk Manag (2011) 0.78
Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection. Dis Markers (2015) 0.78
Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials. Womens Health (Lond Engl) (2011) 0.78
Prevalence of Peripheral Arterial Disease among Adult Patients Attending Outpatient Clinic at a General Hospital in South Angola. Scientifica (Cairo) (2016) 0.77
Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United States. J Int Assoc Provid AIDS Care (2014) 0.77
Omega-3 Fatty acids and vitamin d in cardiology. Cardiol Res Pract (2012) 0.77
Very high-dose cholecalciferol and arteriovenous fistula maturation in ESRD: a randomized, double-blind, placebo-controlled pilot study. J Vasc Access (2013) 0.77
Vitamin d: popular cardiovascular supplement but benefit must be evaluated. Int J Angiol (2011) 0.76
Vitamin D status and coronary flow reserve measured by positron emission tomography: a co-twin control study. J Clin Endocrinol Metab (2012) 0.76
Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population. Bosn J Basic Med Sci (2015) 0.76
Emerging role of vitamin D in colorectal cancer. World J Gastrointest Oncol (2011) 0.76
1,25-Vitamin D3 promotes cardiac differentiation through modulation of the WNT signaling pathway. J Mol Endocrinol (2014) 0.76
25-Hydroxy-vitamin D level may predict presence of coronary collaterals in patients with chronic coronary total occlusion. Postepy Kardiol Interwencyjnej (2015) 0.75
Association between Vitamin D Status and Risk of Peripheral Arterial Disease: The Dong-gu Study. Chonnam Med J (2016) 0.75
Association between serum 25-hydroxyvitamin D and carotid atherosclerotic plaque in Chinese type 2 diabetic patients. Medicine (Baltimore) (2017) 0.75
Extraskeletal actions of vitamin D. Ann N Y Acad Sci (2016) 0.75
Relationship between serum 25-hydroxyvitamin D and lower extremity arterial disease in type 2 diabetes mellitus patients and the analysis of the intervention of vitamin D. J Diabetes Res (2015) 0.75
Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort. Atherosclerosis (2017) 0.75
Association of Serum 25-hydroxy-vitamin D Concentration and Arterial Stiffness among Korean Adults in Single Center. J Bone Metab (2017) 0.75
Vitamin D and its effects on cardiovascular diseases: a comprehensive review. Korean J Intern Med (2016) 0.75
Vitamin D and Cardiovascular Disease: Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox? Curr Cardiovasc Risk Rep (2017) 0.75
Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients. Arch Med Sci (2016) 0.75
Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2017) 0.75
Vitamin D as a risk factor for premature atherosclerosis in patients with type 2 diabetes. Ther Adv Endocrinol Metab (2015) 0.75
Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One (2017) 0.75
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest (2002) 9.50
Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med (1992) 8.94
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation (2004) 7.30
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care (2004) 5.87
The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care (2007) 5.07
Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr (2006) 4.74
Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care (2005) 4.47
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2004) 3.75
25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int (2006) 3.64
Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab (2001) 3.51
Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens (2007) 3.10
Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension (1997) 3.06
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol (2003) 2.97
Ultraviolet B and blood pressure. Lancet (1998) 2.83
25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation (2005) 2.71
Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM (2002) 2.50
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J (2002) 2.38
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A (2007) 2.25
Reduced vitamin D in acute stroke. Stroke (2005) 2.07
Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol (2001) 1.99
Primary hyperparathyroidism and heart disease--a review. Eur Heart J (2004) 1.74
1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol (1997) 1.61
Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr (1995) 1.53
Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol (2005) 1.21
Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int (1996) 1.14
Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med (2002) 1.04
Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun (2002) 1.01
Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol (2006) 0.97
Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet. J Pharmacobiodyn (1981) 0.92
Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int (2004) 0.90
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int (2002) 9.29
Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med (2005) 8.95
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol (2007) 5.91
The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (2012) 4.25
Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2002) 3.77
New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care (2009) 3.73
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology (2003) 3.70
Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics (2009) 3.62
Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med (2011) 3.49
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum (2005) 3.17
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10
Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol (2004) 2.91
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging (2009) 2.86
Blood pressure measurement device, number and timing of visits, and intra-individual visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) (2012) 2.85
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2009) 2.70
Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care (2009) 2.58
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49
Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging (2010) 2.48
Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 2.47
Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009) 2.46
Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med (2015) 2.42
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med (2004) 2.42
Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care (2010) 2.38
Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol (2013) 2.34
Missed dialysis sessions and hospitalization in hemodialysis patients after Hurricane Katrina. Kidney Int (2009) 2.31
Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc (2004) 2.28
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med (2003) 2.22
Effect of Hurricane Katrina on the mortality of dialysis patients. Kidney Int (2009) 2.16
Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation (2005) 2.13
Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med (2014) 2.12
Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) (2007) 2.11
Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am (2009) 2.10
Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
Factors associated with hypertension control in the general population of the United States. Arch Intern Med (2002) 2.01
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis (2006) 2.00
Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol (2009) 1.99
Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol (2007) 1.99
Acute kidney injury and mortality in hospitalized patients. Am J Nephrol (2012) 1.99
Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J (2006) 1.96
Making the case for selective use of statins in the primary prevention setting. Arch Intern Med (2011) 1.90
Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke (2013) 1.89
Health care expenditure prediction with a single item, self-rated health measure. Med Care (2009) 1.87
Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation (2009) 1.85
Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol (2007) 1.84
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect (2008) 1.79
Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation (2004) 1.78
Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis (2009) 1.77
Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension (2010) 1.77
Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclerosis. Hypertension (2010) 1.75
Blood lead level is associated with elevated blood pressure in blacks. Hypertension (2003) 1.75
Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr (2010) 1.73
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J (2005) 1.72
Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010. J Clin Hypertens (Greenwich) (2014) 1.72
25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol (2009) 1.71
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71
Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol (2003) 1.70
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci (2005) 1.68
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment. Am J Kidney Dis (2007) 1.67
Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother (2010) 1.66
Association between urinary albumin excretion and coronary heart disease in black vs white adults. JAMA (2013) 1.65
Measures of adiposity and cardiovascular disease risk factors. Obesity (Silver Spring) (2007) 1.64
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Cardiovasc Imaging (2011) 1.63
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63
Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2011) 1.63
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol (2011) 1.62
Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2004) 1.61
Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol (2002) 1.61